GL1X · GenesisL1 explorer

Research workbench

Eyfp mutant - F165G

Analyse Eyfp mutant - F165G in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6ZQO
Type
protein
Length
229 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
G PROTEIN/GFP fusion protein
UniProt
B7UCZ6
Ligands
CR2, SO4
Pockets
2 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 10% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AG PROTEIN/GFP fusion proteinprotein22910% helix, 51% strandB7UCZ6

Ligands and binding sites

  • CR2 · {(4Z)-2-(aminomethyl)-4-[(4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1530.700.9821CR2
2590.360.7917empty

Modifications

Observed in the structure: 2 cofactor (chromophore).

Compared structures

  • 6ZQO · EYFP mutant - F165G · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.